A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

Andries, Koen, Verhasselt, Peter, Guillemont, Jerome, Göhlmann, Hinrich W. H., Neefs, Jean-Marc, Winkler, Hans, Van Gestel, Jef, Timmerman, Philip, Zhu, Min, Lee, Ennis, Williams, Peter, de Chaffoy, Didier, Huitric, Emma, Hoffner, Sven, Cambau, Emmanuelle, Truffot-Pernot, Chantal, Lounis, Nacer, Jarlier, Vincent·2005·Science
DOI 10.1126/science.1106753

Cited by (2,159)

Items 2,101–2,159 of 2,159

  1. Structural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria
    Courbon, Gautier M, Makarov, Vadim, Cole, Stewart T, Schnapinger, Dirk, Ehrt, Sabine, Rubinstein, John L · 2026 · The EMBO Journal
  2. Innovative platforms for drug discovery against mycobacteria: The success and challenges
    Jahn Nitschke, Thierry Soldati, Nabil Hanna · 2026 · Elsevier eBooks
  3. Decoding BDQ: Structural features, mechanistic action, and anti-TB Efficacy- A review
    Sahil Gawande, Rahul D. Jawarkar, Rahul G Ingle · 2026 · In Silico Research in Biomedicine
  4. Des agents chimiosensibilisants pour lutter contre la résistance aux antibiotiques chez les bactéries Gram-négatif : criblage et caractérisation
    Vincent Lôme · 2017 · theses.fr (ABES)
  5. Investigation of mechanochemical synthesis of condensed 1,4-diazines and pharmaceutically attractive hydrazones
    Paulo F. M. de Oliveira · 2015
  6. Genetic determinants and evolution of drug resistance in Mycobacterium tuberculosis in Vietnam : toward new diagnostic tools
    Quang Huy Nguyen · 2016 · theses.fr (ABES)
  7. Deciphering antimycobacterial activity of cyclophostin/cyclipostins analogs and oxadiazolones derivatives, two new promising family compounds in the treatment of tuberculosis and mycobacterial-related diseases
    Phuong Chi Nguyen · 2018 · theses.fr (ABES)
  8. Régulation post-traductionnelle et recherche d'inhibiteurs de la protéine FadD32, essentielle à la biosynthèse des acides mycoliques chez Mycobacterium tuberculosis
    Nguyen-Hung Le · 2017 · theses.fr (ABES)
  9. MmpL proteins in Mycobacterium abscessus : contribution in glycopeptidolipid transport and in drug resistance
    Ana Victoria Gutiérrez · 2019 · theses.fr (ABES)
  10. Identification and characterization of allosteric sites of UMP kinase
    Patrick Walter · 2019
  11. Impact des antibiotiques sur la réponse des macrophages humains : l'exemple de la bédaquiline
    Alexandre Giraud-Gatineau · 2019 · theses.fr (ABES)
  12. Mécanismes de régulation impliqués dans la résistance aux antibiotiques chez Mycobacterium abscessus
    Matthias Richard · 2019 · theses.fr (ABES)
  13. Mycobacterium leprae : de l’épidémiologie à la caractérisation de l’ADN gyrase
    Florence Reibel · 2018 · theses.fr (ABES)
  14. Conception, synthèse et dévelopement d'inhibiteurs du répresseur transcriptionnel mycobactérien ETHR selon une approche par fragments. Une nouvelle approche dans la lutte contre la tuberculose
    Baptiste Villemagne · 2012 · theses.fr (ABES)
  15. Structural and functional studies of acyl carrier protein post-translational moifications in mycobacterial type I polyketide synthases
    Minh Chau Nguyen · 2019 · theses.fr (ABES)
  16. Implication des enzymes lipolytiques dans la virulence et la survie mycobactérienne
    Pierre Santucci · 2018 · theses.fr (ABES)
  17. Single-cell screening for noise-modulating compounds : an unconventional strategy to tackle antibiotic persistence
    Maxime Mistretta · 2021 · theses.fr (ABES)
  18. Ruminococcins C, a new family of sactipeptides as alternatives to conventional antibiotics
    Clarisse Roblin · 2020 · theses.fr (ABES)
  19. Genetic determinants and evolution of drug resistance in Mycobacterium tuberculosis in Cambodia, high tuberculosis burden country
    Sokleaph Cheng · 2020 · theses.fr (ABES)
  20. Nouvelles cibles et nouveaux régimes thérapeutiques dans le traitement des infections à Mycobacterium abscessus
    Clément Raynaud · 2020 · theses.fr (ABES)
  21. Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation
    Dirk Schnappinger, Steven J. Berthel, Helena I. Boshoff, Inna V. Krieger, Paridhi Sukheja, Saswati Panda, Shree Rath, Kelsey L Briggs, Xuelin Bian, Sari Rasheed et al. · 2026 · EMBO Molecular Medicine
  22. The SUF Machinery from Mycobacterium tuberculosis as a new target for anti-tubercular drugs
    Ingie Elchennawi · 2024 · theses.fr (ABES)
  23. Combating Drug Resistance in Mycobacterium Tuberculosis : A Combinatorial in Silico and Experimental Modeling Approach Toward Novel ATP Synthase Inhibitor Discovery
    Haidy H. El-Zoheiry, Ratul Bhowmik, Ajay Manaithiya · 2026 · Bioinformatics and Biology Insights
  24. From Empirical Discovery to Targeted Therapy: The Evolution of Tuberculosis Treatment
    Natalie J.E. Waller, Kyu Young Rhee · 2026 · Cold Spring Harbor Perspectives in Medicine
  25. Combined lactate- and phosphate-dependent cytoplasmic acidification drives Mycobacterium tuberculosis growth arrest at acidic pH
    Adam P. Kibiloski, Shelby J. Dechow, Bassel J. Abdalla, Heather M. Murdoch, Anna D. Tischler, Robert B. Abramovitch · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Combating Mycobacterial Infections: An Overview of Therapeutic Strategies
    Aishwarya Shaji, Ashima Bhaskar, Ved Prakash Dwivedi, Amit Singh · 2026 · Springer eBooks
  27. 3-Methylthiopropionic Acid Kills Carbapenem-Resistant Klebsiella pneumoniae by Disrupting Membrane Integrity and Bioenergetics
    Lirui Ge, Liang Zhao, Saiwa Liu et al. · 2026 · JACS Au
  28. Combination strategies targeting multiple ETC subunits as a rational approach for drug-resistant TB therapy
    Shashikanta Sau, Puja Kumari Agnivesh, Arnab Roy, Sunil Kumar, Nitin Pal Kalia · 2026 · Archives of Microbiology
  29. A phenotypic in vitro assay of mouse oocyte maturation identifies reversible blockers of meiotic progression for non-hormonal contraceptive discovery
    Jeffrey Pea, Yiru Zhu, Hoi Chang Lee · 2026 · Human Reproduction Open
  30. A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis
    Anastasia I. Ushtanit, Irina V. Peretokina, Ludmila Krylova · 2026 · International Journal of Molecular Sciences
  31. Minimal effective dose of telacebec administered orally in a murine model of leprosy
    Aurélie Chauffour, Charlotte Avanzi, Alexandre Godmer, Corentin Poignon, Natalya V. Serbina, Emmanuelle Cambau, Bettina Broeckling, Josepg Himelspach, John Anderson, Nicolas Véziris et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Synthesis and biological evaluation of quinoline-8-amides as cytochrome bd oxidase inhibitors to combat respiratory flexibility in Mycobacterium tuberculosis
    Rohit Kumar, Arnab Roy, Nitin Pal Kalia, Deepak Kumar Sharma · 2026 · Journal of Molecular Structure
  33. Divergent evolutionary trajectories and mechanistic insights into arsenite and antimonite adaptation in the bacterium Achromobacter sp. As-55
    Yanshuang Yu, Chenqiang Lin, Yu Fang, Paul E. Turner, Barry P. Rosen, Zofia Piotrowska‐Seget, Xianbo Jia, Christopher Rensing · 2026 · Ecotoxicology and Environmental Safety
  34. Reimagining tuberculosis elimination in India: diagnostics, drug resistance, and digital health strategies
    Sneha Jha, Loka Bikash Chaliha, Kshipra Pandey · 2026 · Frontiers in Epidemiology
  35. In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis
    Diana Angélica Aguilar-Ayala, Marie Sylvianne Rabodoarivelo, Maxime Eveque et al. · 2026 · Frontiers in Microbiology
  36. Discovery and Mechanism of Action of a Novel Desloratadine Derivative Inhibiting Mycobacterium tuberculosis 3-Dehydroquinate Synthase
    Aweke Mulu Belachew, Haizhou Li, Xirong Tian et al. · 2026 · Journal of Chemical Information and Modeling
  37. Phytochemical Analysis and Bioactivities of Dombeya rotundifolia and Lippia javanica
    Matsilane L. Mashilo, Mashilo Mash Matotoka, Ofentse Mazimba · 2026 · Plants
  38. The unusual anti-cancer activity of the Cu(II)-bedaquiline complex
    Thomas J. Manning, Pearce Persaud · 2026 · Indian Journal of Tuberculosis
  39. Prospective observational study of QTc prolongation and sputum culture conversion with bedaquiline- and delamanid-based regimens in drug-resistant tuberculosis at a tertiary care centre in India
    Seema Gogoi, RajKumar Arya, K. P. Ranjan · 2026 · Indian Journal of Tuberculosis
  40. BVL3572S inhibits HisC and AlaA, exploiting vitamin B6 dependency to kill Mycobacterium tuberculosis
    Zainab Edoo, Astrid Lenne, Camille Grosse, Marie Devaere, Marion Michel, Guillaume Caron, Ernesto Anoz‐Carbonell, Kamel Djaout, Rosangela Frita, Cyril Gaudin et al. · 2026 · Cell chemical biology
  41. A new horizon in tuberculosis control: a review of novel drug targets, mechanisms, and advanced therapeutic strategies
    Joseph Opeolu Ashaolu, Sylvain Y. M. Some · 2026 · All Life
  42. Quinoline Scaffold in Drug Discovery: Synthetic Strategies, Therapeutic Applications, and Emerging Drug Candidates
    Ayoub El‐Mrabet, Amal Haoudi-Mazzah, Amine Ez‐zoubi, Rachid Bouzammit, Abdellatif Alami, Ahmed Mazzah · 2026 · Scientia Pharmaceutica
  43. 4-Styrylquinoline-3-carboxylates/carboxamides as new anti-Mycobacterium tuberculosis chemotypes: Design, synthesis, biological evaluation, and molecular modelling
    Kshitij I. Patel, Nirjhar Saha, Jyothi Kumari · 2026 · Journal of Molecular Structure
  44. The Antimycobacterial Activity, Toxicity and Chemical Composition of South African Propolis
    N.F. Mzimba, Efficient N. Ncube, Elliasu Yakubu Salifu, Alvaro M. Viljoen, Bhavna Gowan Gordhan, Bavesh Davandra Kana, Sandy F. van Vuuren · 2026 · Chemistry & Biodiversity
  45. Targeting the respiratory chain: from bioenergetic inhibition to metabolic reprogramming
    Zheng Wan · 2026 · Targetome
  46. Heterobenzamides exhibit bacteriostatic activity against intracellular Mycobacterium tuberculosis by targeting aerobic respiration
    Aditi Deshpande, Tanya Parish · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Structural and Mechanistic Studies of ADEPs Yield Potent Antibacterials and a Drug Formulation Strategy for Tuberculosis
    Fan Fei, C.M. Burnside, Shichun Lun, Denise Wee, Manpreet Kaur, Henry R. Anderson, Matthew N. McCarroll, Abigail Richardson, Sophia Neglia, Hannah M. Liu et al. · 2026 · Journal of Medicinal Chemistry
  48. Efficacy of quabodepistat alone and in combination with delamanid and bedaquiline against Mycobacterium tuberculosis in an NHP model evaluated by [ 18 F] FDG PET/CT and bacterial burden
    Laura E. Via, J. Sarathy, Danielle M. Weiner et al. · 2026 · Antimicrobial Agents and Chemotherapy
  49. Quinolin(on)es and pyridin(on)es as promising scaffolds against mycobacterial infections
    Marie Greverie, Alexandra Dassonville‐Klimpt, Morgane Choquet, Claire Andréjak, Pascal Sonnet · 2026 · Bioorganic & Medicinal Chemistry Letters
  50. Design, Synthesis, and Antimicrobial Activity of Novel Cyt- bd Inhibitors Targeting Energy Compensation in Mycobacterium tuberculosis
    Qiao Qin, Zhuoheng Liu, Chen‐Yi Cheung, Jinxu Xu, Sadaf Kalsum, Hang Yu, Maria Lerm, Hongri Gong, Matthew B. McNeil, Gregory Murray Cook et al. · 2026 · ACS Medicinal Chemistry Letters
  51. A Small Molecule Dual Inhibitor of agr Quorum Sensing and ATP Synthase Blocks Acute and Chronic Virulence Phenotypes in Staphylococcus aureus
    Troy D. Vulpis, Jordan T. York, A. P. Clay, Thomas J. Polaske, Samuel W. Markovich, Kijeong Lee, Douglas H. Chang, Sean P. Palecek, David M. Lynn, John‐Demian Sauer et al. · 2026 · ACS Infectious Diseases
  52. Inhibition of type II NADH dehydrogenase in Mycobacterium tuberculosis reveals collateral vulnerability in the electron transport chain
    Vien Q. T. Ho, Vincent Fontaine, Ernesto Anoz‐Carbonell et al. · 2026 · Antimicrobial Agents and Chemotherapy
  53. Diisonitrile Chalkophore Structure and Function in Mycobacterial Copper Acquisition
    Pooja B. Pandya, Chad E Hatch, John A. Buglino · 2026 · Journal of the American Chemical Society
  54. Bedaquiline pharmacokinetics in drug-resistant tuberculosis: from exposure variability to individualized therapy
    Yu Xiong, Junli Wang, Dong-Yan Wei · 2026 · Frontiers in Pharmacology
  55. A Multi‐Scale Computational Framework for Anti‐Persister Tuberculosis Drug Discovery
    Said Moshawih, Anguraj Moulishankar, Chee‐Yan Choo, Khang Wen Goh, Chrismawan Ardianto, Azam Che Idris, Long Chiau Ming · 2026 · Chemical Biology & Drug Design
  56. Clinical Development of Antibacterial Drugs: Recent Progress and Future Outlook
    Dipak Kathayat, Andrea Vidovszky, Yaasmeen Khan, Ashley Denk, Asmita Paudel, Ashutosh Verma, Yosra A. Helmy, Gireesh Rajashekara · 2026 · Antibiotics
  57. Studies into the role of peptidoglycan glycolylation in mycobacterial dormancy and resuscitation
    Jessica Loraine · 2013 · Leicester Research Archive (University of Leicester)
  58. Fortschritte in der Therapie der Tuberkulose
    Ralf Otto-Knapp, Lena Bös, T. Schaberg · 2013 · Der Pneumologe
  59. Caracterização bioquímica, dinâmica molecular e propriedades imunomoduladoras da prolil oligopeptidase de Mycobacterium tuberculosis
    Brina Portugal · 2014 · Americanae (AECID Library)